Transcription of Infection (MDRO/CDI) Module
{{id}} {{{paragraph}}}
January 2022 12-1 multidrug -Resistant Organism & Clostridioides difficile Infection (MDRO/CDI) Module Table of Contents Background: 2 Table 1. Core and Supplemental Reporting Choices for MDRO and CDI Module 3 Section I: Core Reporting 5 Laboratory-Identified (LabID) Event Reporting 5 1A: MDRO LabID Event Reporting 6 Figure 1. MDRO Test Result Algorithm for All Specimens Laboratory-Identified (LabID) Events 9 Figure 2.
CRE, and/or multidrug-resistant . Acinetobacter . spp. (see definitions below). For . S. aureus, both the resistant (MRSA) and the susceptible (MSSA) phenotypes can be tracked to provide concurrent measures of the susceptible pathogens as a comparison to those of the resistant pathogens in a setting of active MRSA prevention efforts. Note:
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}